Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
CHUGAI PHARMA extends gains as U.S. FDA approves Eli Lilly's oral obesity drug Founayo
CHUGAI PHARMACEUTICAL CO., LTD. <4519> continued to rise. Eli Lilly
Source: MINKABU PRESS
Related Articles
OKUWA's FY02/26 Results Fall Short of Guidance
Hong Kong's Hang Seng Index Closes at 25,294.03 (+505.89) on the 1st
BOJ exchange rates at 5 p.m.: yen strengthens to \158.79-80 per dollar
Key International Commodity Market Prices on the 1st
LIFEDRINK COMPANY falls for first time in 5 days as profit-taking outweighs Iris Ohyama's consecutive stake increase reports
Vitabrid Japan debuts at \1,301, 5.0% below IPO price
QPS HD, Astroscale HD and other space development-related stocks surge on successful Artemis launch attracting investment flowsâ—‡
Active Stocks (Close): SAMCO, REFINVERSE Group, Nxera Pharma and others
Kringle Pharma hits daily limit up on patent registration for chronic spinal cord injury treatment
V-cube hits daily limit down amid \40 squeeze-out plan